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Exosome-like vesicles containing virulence factors, enzymes, and antigens have recently been characterized
in fungal pathogens, such as Cryptococcus neoformans and Histoplasma capsulatum. Here, we describe extracel-
lular vesicles carrying highly immunogenic -linked galactopyranosyl (-Gal) epitopes in Paracoccidioides
brasiliensis. P. brasiliensis is a dimorphic fungus that causes human paracoccidioidomycosis (PCM). For vesicle
preparations, cell-free supernatant fluids from yeast cells cultivated in Ham’s defined medium-glucose were
concentrated in an Amicon ultrafiltration system and ultracentrifuged at 100,000  g. P. brasiliensis antigens
were present in preparations from phylogenetically distinct isolates Pb18 and Pb3, as observed in immunoblots
revealed with sera from PCM patients. In an enzyme-linked immunosorbent assay (ELISA), vesicle compo-
nents containing -Gal epitopes reacted strongly with anti--Gal antibodies isolated from both Chagas’
disease and PCM patients, withMarasmius oreades agglutinin (MOA) (a lectin that recognizes terminal -Gal),
but only faintly with natural anti--Gal. Reactivity was inhibited after treatment with -galactosidase. Vesicle
preparations analyzed by electron microscopy showed vesicular structures of 20 to 200 nm that were labeled
both on the surface and in the lumen with MOA. In P. brasiliensis cells, components carrying -Gal epitopes
were found distributed on the cell wall, following a punctuated confocal pattern, and inside large intracellular
vacuoles. Lipid-free vesicle fractions reacted with anti--Gal in ELISA only when not digested with -galac-
tosidase, while reactivity with glycoproteins was reduced after -elimination, which is indicative of partial
O-linked chain localization. Our findings open new areas to explore in terms of host-parasite relationships in
PCM and the role played in vivo by vesicle components and -galactosyl epitopes.
Paracoccidioides brasiliensis is the fungus responsible for
paracoccidioidomycosis (PCM). It is a thermodimorphic fun-
gus that grows in the yeast phase at 37°C and as mycelium at
temperatures below 26°C. One of the best-acknowledged mo-
lecular features that parallels this morphological change is an
alteration in structural cell wall glucans from -1,3-linked glu-
can in the mycelium phase to mostly -1,3-linked glucan in the
yeast phase, as well as an increment in chitin content (34).
Infection starts with inhalation of P. brasiliensis conidia present
in the environment and subsequent transformation into yeasts
in the pulmonary alveoli. PCM is a systemic granulomatous
mycosis prevalent in Latin America, where roughly 10 million
individuals could be infected (34). Active PCM mainly affects
the lungs, but the fungus can disseminate to any other organ.
Cellular immunity is responsible for protection, while antibody
titers tend to reflect disease severity; therefore, detection of
antifungal components can be useful in diagnosis, and espe-
cially in the prognosis of the disease. On the other hand, mouse
protection and immunotherapy with monoclonal antibodies
have been achieved using the gp43 and gp70 antigens as targets
(11, 15). gp43 is a secreted glycoprotein that elicits both cel-
lular and humoral immune responses; it is the main diagnostic
antigen so far characterized in P. brasiliensis (38).
Exosomes have been recognized as important structures re-
lated to the virulence of microorganisms and modulation of the
host’s immunity (39). Exosome-like vesicles carrying virulence
factors, enzymes, and antigens have recently been character-
ized in fungal pathogens, such as Cryptococcus neoformans and
Histoplasma capsulatum (3, 33). In these microorganisms,
membranous vesicular structures could be seen crossing the
cell wall and being exported to the extracellular milieu. Extra-
cellular vesicles could then be recovered by ultracentrifugation
of culture supernatants. Ergosterol and glucosylceramide have
been detected in extracellular vesicles from live (but not heat-
killed) C. neoformans, suggesting that they are produced and
secreted by viable yeasts as opposed to being a product of cell
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debris (33). In C. neoformans, membranous vesicles carry glu-
curonoxylomannan (GXM), the major capsular polysaccha-
ride, to the extracellular space. The polysaccharide is then
released and reincorporated into the cell surface as a parallel
mechanism of capsule growth (32, 33, 42). Vesicles containing
GXM have also been shown to be produced during macro-
phage infection, suggesting a role in the pathogenesis of the
microorganism (26). Indeed, proteomic and lipidomic analyses
of vesicles isolated from culture supernatants from both C.
neoformans (32) and H. capsulatum (3) have evidenced the
presence of virulence factors and enzymes. Microscopic anal-
ysis identified a heterogeneous population of extracellular ves-
icles, not only in C. neoformans (32, 33), but also in H. capsu-
latum, Saccharomyces cerevisiae, Candida albicans, Candida
parapsilosis, and Sporothrix schenckii (3, 27), pointing to the
existence of sophisticated mechanisms of vesicle biogenesis in
fungi (14). Trocoli Torrecilhas et al. (37) described the role of
extracellular vesicles from Trypanosoma cruzi in the patho-
genesis of Chagas’ disease. Major components of extracellular
vesicles from T. cruzi trypomastigotes are glycoproteins of the
gp85 trans-sialidase superfamily and glycoconjugates bearing
-linked galactosyl epitopes (-Gal). Cell components bearing
-Gal epitopes are recognized by anti--Gal IgG antibodies
that can be isolated from patients with chronic Chagas’ disease
by affinity chromatography using immobilized Gal1-3Gal1-
4GlcNAc (6). Chagasic (Ch) anti--Gal IgG is a lytic antibody,
i.e., it can agglutinate and cause parasite lysis by a comple-
ment-mediated (6) or -independent (4, 5, 29) mechanism.
In the present work, we characterized extracellular vesicles
from P. brasiliensis isolates Pb18 and Pb3. Pb18 represents the
major paraphyletic group S1 of the Paracoccidioides complex
(23, 36) and has been widely used by researchers due to its
virulence (12); Pb3 represents a cryptic PS2 species. We have
previously shown that the progression of experimental PCM in
B10.A mice differed when infections caused by isolates from S1
(more virulent) and PS2 isolates were compared (13). We show
here that vesicles from both isolates carry antigenic molecules
that are recognized by total sera and anti--Gal antibodies
from PCM patients. We also demonstrate that P. brasiliensis
is enriched with glycoconjugates containing -galactosyl
epitopes, which are largely expressed on the fungal cell wall
and are stored in intracellular vacuoles.
MATERIALS AND METHODS
P. brasiliensis isolates and growth conditions. P. brasiliensis isolates Pb3 and
Pb18 (described in reference 24) were used in this work. The isolates were
maintained in the yeast phase at 36°C in slants of modified YPD (mYPD)
medium (0.5% yeast extract, 0.5% casein peptone, and 1.5% glucose, pH 6.5).
For isolation of extracellular vesicles, yeast cells were transferred from 7-day-old
slants to Erlenmeyer flasks containing 200 ml of defined Ham’s F-12 medium
(Invitrogen) complemented with 1.5% glucose (F-12/glc) and cultivated for 5
days at 36°C with shaking (preinocula). Cell pellets from four preinocula were
collected, inoculated in 500 ml of fresh medium, and cultivated for 48 h for
vesicle purification. Control cultures for sterol analysis of the vesicles were grown
in parallel, and the cell precipitates from preinocula were heat killed at 55°C for
2 h, inoculated in 500 ml of fresh medium, and cultivated for 2 days before
processing of the cell-free supernatant.
Isolation of extracellular vesicles. Vesicles were isolated from P. brasiliensis
culture supernatants following subtle modifications of the protocol described by
Rodrigues et al. (33). All the steps were carried out in ice or at 4°C to avoid
vesicle rupture and/or fusion. Sequential centrifugations of liquid cultures at
4,000  g (15 min) and 15,000  g (30 min) were followed to remove whole cells
and smaller debris. The pellets were discarded, and the cell/debris-free super-
natants were concentrated 20-fold using an Amicon ultrafiltration system (100-
kDa cutoff). Concentrated supernatants containing high-molecular-weight com-
ponents were centrifuged at 15,000  g (30 min) to remove aggregates, and the
resulting supernatant was then ultracentrifuged at 100,000  g for 1 h to pre-
cipitate vesicles. The pellets were either suspended in phosphate-buffered saline
(PBS) (250 to 300 l) for Western blotting and enzyme-linked immunosorbent
assay (ELISA) analyses or processed for cryosections and immunogold assays.
Preparation of whole-cell lysates. P. brasiliensis yeast cell pellets were washed
twice in PBS containing proteinase inhibitors {1 mM phenylmethanesulfonyl-
fluoride, 1 M pepstatin A, 1 mM o-phenanthroline, and 10 M E-64 [trans-
epoxysuccinyl-L-leucylamido(4-guanidino)butane]}, mixed with similar volumes
of glass beads (425 to 600 m; Sigma) and double the volume of PBS, and then
vigorously agitated in a vortex (15 times for 30 s, with 30-s intervals in ice). The
cell debris was pelleted by centrifugation (5,600  g), and the supernatant was
stored in aliquots at 20°C for further analysis.
Vesicle fractionation and analysis by HPTLC. For sterol analysis by high-
performance thin-layer chromatography (HPTLC), extracellular vesicle pellets
from P. brasiliensis Pb18 were processed as described by Rodrigues et al. (33).
The pellets were suspended in methanol, and two volumes of chloroform were
added. The mixture was vortexed and centrifuged to discard precipitates, and the
supernatants were dried by vacuum centrifugation and then partitioned accord-
ing to the method of Folch et al. (16). The lower phase, containing neutral lipids,
was loaded into HPTLC silica plates (Si 60F254s; LiChrospher, Germany) and
separated using a solvent system containing hexane-ether-acetic acid (80:40:2
[vol:vol:vol]). The sterol spots were identified after the plate was sprayed with a
solution of 50 mg ferric chloride (FeCl3) dissolved in a mixture of 90 ml H2O, 5
ml acetic acid, and 5 ml sulfuric acid. The sprayed plates were incubated at 100°C
for 5 min. For ELISA analysis of lipid and lipid-free vesicle fractions, vesicle
preparations were extracted with methanol-chloroform, as described previously;
both the pellet (lipid free) and the dried supernatant (lipids) were then analyzed.
Isolation of anti--galactosyl IgG from patients’ sera. Ch and PCM anti--Gal
were isolated through affinity chromatography on Synsorb 115 resin containing
the trisaccharide Gall-3Gal1-4GlcNAc (Chembiomed, Edmonton, Canada)
and subsequently on protein A-Sepharose (Amersham Biociences), as described
by Almeida et al. (6). Anti--Gal antibodies from healthy individuals (normal
human serum [NHS] anti--Gal) were isolated similarly. IgG was quantified by
optical density readings (1.0 A280 unit  750 g/ml IgG).
TEM and immunogold labeling. For transmission electron microscopy (TEM)
analysis of P. brasiliensis yeasts, cells from logarithmic-phase cultures grown in
liquid mYPD medium were processed in fixative solutions and embedded in
hydrophobic Spurr resin exactly as described by Batista et al. (9). For immuno-
gold labeling, both P. brasiliensis Pb18 cells and vesicle pellets obtained after
centrifugation at 100,000  g were processed as described by Rodrigues et al.
(33). Briefly, cryosections were obtained in a temperature range from 70°C to
90°C using an Ultracut cryoultramicrotome (Reichert). After being blocked in
acetylated bovine serum albumin (cBSA) (Aurion)-PBS and 50 mM NH4Cl, the
cryosections were incubated overnight at 4°C with 20 g/ml of gold-labeled
Marasmius oreades agglutinin (MOA) lectin (EY Laboratories; 5 nm) or Ch
anti--Gal IgG (50 g/ml in 1% cBSA-PBS), followed by a 1-h incubation with
12-nm colloidal-gold–goat anti-human IgG (Jackson ImmunoResearch; 1:20 in
1% cBSA-PBS). Control grids incubated with MOA-gold particles were treated
with green coffee bean -galactosidase (Sigma Aldrich), and Ch anti-Gal con-
trol grids were processed in the absence of primary antibodies. Samples were
examined in a JEOL 1200 EX-II electron microscope. Quantification of immu-
nogold labeling was done by counting gold particles per nm2 in the regions of
interest.
Confocal microscopy. P. brasiliensis yeast cells from isolate Pb18 growing in
F-12/glc aerated liquid cultures in logarithmic phase were collected, washed
twice in PBS, adjusted to 3  106 viable cells/ml, and fixed for 30 min in cold
methanol (80%), 4% formamide, 1% glutaraldehyde, which also made the cells
permeable. Cell pellets were incubated with 3% (wt/vol) BSA in PBS (blocking
buffer) for 4 h at room temperature, washed three times with PBS, and then
incubated with 100 g/ml of Ch, PCM, or NHS anti--Gal IgG for 16 h at 4°C.
The cells were then incubated for 2 h in the dark with Alexa Fluor 488 goat
anti-human IgG (Invitrogen) in blocking buffer at 1:200 dilution. Between incu-
bation steps with antibodies, the fungal cells were washed six times with PBS.
Each suspension (10 l) was prepared on glass slides with Vectashield mounting
medium (Vector Laboratories, Inc., Burlingame, CA) and analyzed using a laser
scanning confocal microscope (LSM-510 Axiovert; Carl Zeiss, Jena, Germany).
ELISA and immunoblotting. To analyze the reactivity of both biotinylated
MOA and Ch anti--Gal IgG with vesicle preparations and whole-cell extracts
from P. brasiliensis Pb3 and Pb18, 96-well microplates (Nunc) were coated with
1 nM vesicle sterol contents (estimated with the Amplex Red Cholesterol Assay
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kit) or cell extracts expressed as protein contents (estimated with Bradford’s
protein assay [10]). When applied, treatment with -galactosidase was carried
out with substrate immobilized to the microplates. The microplates were incu-
bated overnight at 4°C, and nonspecific interactions were blocked with 5% skim
milk in PBS for 4 h at 36°C or with 0.1% BSA-PBS overnight at 4°C. A concen-
tration of 70 g/ml of biotinylated MOA or 2.5 to 10 g/ml Ch anti--Gal diluted
in 0.1% BSA-PBS was used to react with vesicle preparations upon incubation
for 4 h at 36°C or overnight at 4°C. This step was followed by a 1-h incubation
with peroxidase-conjugated sheep anti-human IgG or peroxidase-conjugated
streptavidin (1:1,000 in 0.1% BSA-PBS). The reactions were visualized using a
chemiluminescent substrate (Pierce or Millipore ECL substrate), and the results
were recorded in a microplate luminometer. ELISA with lipid fractions extracted
from vesicles was carried out as described previously (25), with solvent-washed
96-well plates coated with lipids diluted in methanol and evaporated to dryness
at room temperature. ELISA data were recorded (in relative luminescence units
[RLU]) as mean values from triplicates, with standard deviations. The values of
negative controls in the absence of either antibodies or substrate were subtracted
from the values obtained for test samples.
For immunoblotting, about 6% of one vesicle preparation batch (500 ml
culture) from P. brasiliensis was subjected to electrophoresis in a 10% SDS-
polyacrylamide gel (21) and electrotransferred to nitrocellulose membranes. The
incubation conditions with antibodies and conjugates were as described above for
ELISA and elsewhere (17). For silver staining (8), about half of a vesicle prep-
aration (500 ml culture) was necessary for band visualization.
Deglycosylation with endoglycosidase H and -elimination. Vesicle and
whole-cell extract preparations of P. brasiliensis Pb18 were treated with endogly-
cosidase H (Endo H; Sigma Aldrich) to removed high-mannose N-linked oligo-
saccharides in 50 mM sodium citrate buffer, pH 5.0, for 48 h at 36°C. Control
samples were incubated in the absence of enzyme. Chemical treatment with 1 M
NH4OH for 48 h at 36°C was used to remove O-linked glycan chains (20). The
proteinase inhibitors E-64 (15 M) and pepstatin (1 M) were added in all
reactions.
Statistical analysis. We used Student’s t test to analyze the significance of our
results.
RESULTS
Characterization of extracellular vesicles. The presence of
extracellular vesicles produced by P. brasiliensis was evidenced
by TEM. In rare images, vesicles could be seen at the surface
of the cell wall in preparations of yeast cells growing in both
mYPD medium (Fig. 1A) and F-12/glc (not shown). In order to
isolate extracellular vesicles from culture supernatants, yeast
cells were cultivated for 48 h in F-12/glc medium starting from
heavy preinocula constituted of cell precipitates from 5-day-
old logarithmic cultures. The estimated average sterol yields
from two different preparations were 38 ng sterol/ml of cells
(wet pellet) for Pb3 and 65 ng sterol/ml of cells for Pb18.
Preparations from 500-ml cultures resulted in wet cell pellets
of about 6 ml for Pb3 and 8 ml for Pb18. Figure 1B shows the
presence of vesicles smaller than 100 nm in a representative
100,000  g pellet. The lipid bilayer membrane can be seen in
a representative vesicle (Fig. 1C and D, labeled with MOA-
gold particles).
To confirm that the vesicles originated from exosomal bi-
layer formation and not from membranes released from dead
cells, we analyzed a control 100,000  g pellet preparation
obtained from culture supernatants of heat-killed P. brasiliensis
yeast cells, in parallel with live cells. HPTLC detected sterols
migrating next to ergosterol only in preparations from live-cell
cultures (Fig. 2), suggesting that membranes did not result
from cell debris. Similar results have previously been obtained
for C. neoformans (33).
Preliminary evidence of extracellular vesicles in P. brasilien-
sis cultures has been obtained by our group from a series of
studies with the Pb339 isolate (A. L. Matsuo, L. Ganiko, I. C.
Almeida, and R. Puccia, unpublished data). In the present
work, we used Pb18 as a model but compared some antigenic
characteristics with Pb3 vesicle preparations. Silver-stained
SDS-PAGE profiles of vesicle preparations from Pb18 and Pb3
were similar, with visible components migrating within molec-
FIG. 1. (A to C) TEM images of a P. brasiliensis yeast cell (A) and vesicle pellets from two different preparations (B and C). In panel A, vesicles
are seen at the surface (arrows) outside of the cell wall (CW). (D) Detail of the boxed area of the vesicle shown in panel C allowing visualization
of a double-layer membrane structure. The dark dots in panel C are MOA-labeled gold particles, as explained in the text. Scale bars of 100 nm
(A and B) and 50 nm (C) are included.
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ular masses between 98 and 50 kDa (Fig. 3). The stacking gel
did not stain, suggesting that most components had indeed
been resolved in the running gel. Some vesicle components
were recognized specifically by sera from a pool of PCM pa-
tients in immunoblotting (Fig. 3), as opposed to the complete
lack of reactivity with a pool of sera from healthy individuals
(NHS). A reactive broad smear was clearly seen in both Pb18
and Pb3 preparations, as well as three other bands with masses
estimated as 49 kDa, 64 kDa, and 75 kDa. A high-molecular-
mass antigenic band was observed in Pb3 and only faintly in
Pb18; a 47-kDa component was revealed only in Pb3, whereas
two weak and thin bands slower than 82 kDa were observed
only in Pb18 preparations.
Finding -Gal epitopes in P. brasiliensis vesicles. While
looking for vesicle markers, we surprisingly detected strong
reactivity in ELISA of P. brasiliensis preparations from both
Pb3 and Pb18 with anti--galactosyl IgG isolated from patients
with chronic Chagas’ disease (Fig. 4, left). Immunoreactivity
with Pb3 and Pb18 preparations decreased about 45% upon
treatment with green coffee bean -galactosidase in two sets of
experiments. Figure 4 shows one of these experiments, where
the enzyme was used to compete with binding of the anti--
galactosyl IgG. These results suggested the involvement of
terminal -galactosyl epitopes in the reaction and were cor-
roborated by intense reactivity in ELISA with MOA lectin
(Fig. 4, right), which specifically binds to terminal nonreducing
Gal1,3Gal moieties (41). The reactivity with MOA lectin de-
creased about 75% upon treatment of P. brasiliensis vesicles
from both Pb3 and Pb18 with -galactosidase (Fig. 4, right) in
single experiments, supporting similar results previously ob-
tained with vesicles from Pb339.
TEM images confirmed the ELISA data and revealed
immunogold labeling with MOA lectin on the surfaces and
in the lumen of Pb18 vesicles (Fig. 5A, B, and C). Negative
controls—vesicles treated with -galactosidase—had de-
creased reactivity (Fig. 5D), as indicated by particle counts
(Fig. 5E), once again suggesting the presence of vesicular
components carrying -galactosyl residues that are involved
in lectin binding.
Isolation of PCM -Gal IgG and confocal and immunogold
microscopy. We managed to isolate anti--Gal IgG from a
pool of PCM patients’ sera using the same methodology em-
ployed to purify Ch anti--Gal (6). Since we did not have
access to large volumes of PCM patients’ sera, only a few
experiments were carried out with PCM anti--Gal. In Fig. 6,
left, note that it reacted in ELISA with Pb18 vesicle prepara-
tions in a dose-dependent manner, while at comparable anti-
body concentrations, NHS anti-Gal purified from healthy in-
dividuals reacted poorly. For both Pb3 and Pb18 vesicles, the
reactivity with PCM anti--Gal was significantly inhibited by
FIG. 2. HPTLC of extracellular 100,000  g pellets obtained from
supernatant cultures of live or heat-killed (HK) yeast cells. Ergosterol
(arrow) was used as a standard. #, origin of the chromatogram. For
this experiment, one batch of vesicle preparation (500 ml culture) was
used for sterol extraction and visualization in the chromatogram. Our
best results are shown.
FIG. 3. Silver-stained components and antigenic profiles of Pb3
and Pb18 vesicle preparations in reducing SDS-PAGE 10% gels. An-
tigenic profiles are seen in immunoblots revealed with a pool of PCM
patients’ sera, compared with a pool of sera from healthy individuals
(NHS), both tested at 1:1,000. The asterisks indicate migrations of
differentially reactive components. The positions of mass markers
(kDa) are indicated on the left. sg, stacking gel.
FIG. 4. Reactivity in ELISA of Pb18 and Pb3 vesicle preparations
with Ch anti--Gal antibodies (left) or MOA lectin (right). The prep-
arations were previously treated () or not () with -galactosidase.
The percentages of inhibition after treatment with -galactosidase are
indicated. The asterisks denote statistical significance (P  0.05). The
error bars indicate standard deviations.
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-galactosidase between 34% and 38%, pointing to the in-
volvement of terminal -galactosyl epitopes in the reaction.
When PCM anti--Gal was used to localize the correspond-
ing epitopes in P. brasiliensis yeast cells by confocal micros-
copy, we observed intense labeling that was comparable to that
obtained with Ch anti--Gal (Fig. 7). In both cases, fluores-
cence was distributed in a punctuated pattern, which is com-
patible with vesicular distribution. The same pattern was ob-
served on the cell surface and inside the cell (Fig. 7). NHS
anti--Gal stained the P. brasiliensis cells poorly and diffusely,
following a background pattern. Intracellular localization of
-galactosyl epitopes was also suggested by ELISA carried out
with cell lysates, for which the patterns of dose-response reac-
tivity with PCM and NHS anti--Gal were similar to those
observed in Fig. 6 (not shown). When Pb18 yeast cells were
incubated with Ch anti--Gal and analyzed by TEM, immuno-
gold particles were abundantly observed on the cell wall (Fig.
8A) and inside vacuoles (Fig. 8B), but not in negative controls
(Fig. 8C and D). Labeling in these compartments was specific,
as indicated by particle counting (Fig. 8E). Labeling in vesicle-
like structures inside the vacuoles is suggested in Fig. 8B.
Nature of -Gal-containing components. In T. cruzi,
-galactosyl epitopes are part of O-linked glycans found in
mucins (5). In P. brasiliensis, we investigated the nature of
protein moieties carrying -Gal epitopes by treating vesicle
and cell lysate preparations of P. brasiliensis Pb18 either with
Endo H, to remove N-linked mannose chains, or mildly with
NH4OH (-elimination), to remove O-linked glycans. The
treated samples were compared with controls by ELISA reac-
tivity with both PCM and Ch anti--Gal. Figure 9A shows
percentages of inhibition up to 35% after -elimination, sug-
gesting that at least part of the P. brasiliensis epitopes recog-
nized by PCM and Ch anti--Gal are found in oligosaccharides
O linked to proteins. Smaller percentages of inhibition were
obtained with Pb18 vesicles, and differences in the nature of
-Gal epitopes between Pb18 and Pb3 have to be better inves-
tigated. Our results with Endo H Pb3 vesicles also suggest that
some -Gal epitopes could be expressed in N-linked chains,
since inhibitions of about 10% were seen.
To better investigate the localization of -Gal epitopes, we
fractionated Pb3 and Pb18 vesicle preparations into lipid and
lipid-free fractions and tested the products by ELISA with
anti--Gal before and after treatment with -galactosidase.
Figure 9B shows that lipid-free fractions reacted with both
PCM and Ch anti--Gal, and this reaction was highly inhibited
by -galactosidase. Lipid fractions were also tested, but the
results were not reproducible, probably because of the small
amounts of substrate used in the reactions. We did, however,
observe reactivity with lipid fractions at least once, which was
completely abolished after -galactosidase treatment. There-
fore, -Gal epitopes in P. brasiliensis glycolipids are likely to
occur, but this has to be better investigated.
DISCUSSION
The present work described the presence of extracellular
vesicles in the yeast phase of P. brasiliensis for the first time by
using isolate Pb18 as a model and comparing some antigenic
characteristics of vesicle preparations with the phylogenetically
distinct isolate Pb3. We showed that P. brasiliensis extracellular
vesicles carry antigenic components bearing highly immuno-
FIG. 5. TEM images of two distinct vesicle preparations (panel A and panels B, C, and D) incubated with MOA-labeled gold before (A, B, and
C) and after (D) treatment with -galactosidase. (E) Quantification of the gold particles showed decreased labeling after treatment with the
enzyme. The error bars indicate standard deviations. Scale bars of 100 nm (A) and 50 nm (B, C, and D) are included.
FIG. 6. (A) Reactivity in ELISA of a Pb18 vesicle preparation with
different concentrations of either PCM or natural (NHS) anti--Gal.
(B) Reactivity in ELISA of 2.5 g/ml of PCM anti--Gal with Pb3 and
Pb18 vesicle preparations treated () or not () with -galactosidase.
Similar percentages of inhibition were obtained in replicates. The
asterisks indicate statistical significance (P  0.05). The error bars
indicate standard deviations.
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genic -linked galactosyl epitopes. In the cells, components
bearing -Gal epitopes were found abundantly distributed on
the cell wall, following a confocal punctuated pattern, but they
were also stored inside large intracellular vacuoles. The
-galactosyl-containing components from P. brasiliensis re-
acted strongly in ELISA with anti--Gal antibodies isolated
from both Chagasic and PCM patients and with MOA lectin,
but only weakly with natural anti--Gal from healthy individ-
uals.
Natural immunoglobulins specifically recognizing nonreduc-
ing terminal -galactosyl epitopes are prevalent in sera from
healthy individuals and account for about 1% of the total IgG.
These antibodies preferentially bind to terminal Gal1,
3Gal1,4GlcNAc-R trisaccharide (Galili epitope), which is
absent in humans, apes, and Old World monkeys (reviewed
in reference 22). By eliminating self -Gal epitope through
mutation in the -1,3-galactosyltransferase gene, protective
antibodies would be produced against microorganisms. In-
deed, viruses, bacteria, and protozoa can express a variety of
-Gal epitopes; reactivity with the host’s anti--Gal might
cause elimination of the infectious agent (22). In T. cruzi,
the causative agent of Chagas’ disease, -galactosyl epitopes
FIG. 7. Confocal microscopy of P. brasiliensis yeast cells comparatively labeled with natural (NHS), PCM, and Ch anti--Gal, as indicated. Both
immunofluorescence and merged images with phase-contrast are shown. Scale bars are included.
FIG. 8. (A and B) Cell wall (A) and vacuolar (B) localization of components bearing -Gal epitopes in P. brasiliensis yeast cells incubated with
Ch anti--Gal. (C and D) Negative controls lacked the primary Ch anti--Gal antibody. (E) Quantification of gold particles was negligible in the
Formvar grids and in the cytoplasm. Higher labeling was detected on the cell wall (CW) and vacuole. The error bars indicate standard deviations.
Scale bars of 500 nm (A and C), 250 nm (B), and 200 nm (D) are included.
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are part of long and complex sugar chains that are O linked
mainly to threonine residues of glycosylphosphatidylinositol
(GPI)-anchored mucin-like glycoproteins (4, 5). Chagasic
anti--Gal IgG from patients with chronic Chagas’ disease
purified by affinity chromatography through immobilized
Gal1,3Gal1,4GlcNAc is able to recognize epitopes termi-
nating in Gal1,2Gal, Gal1,3Gal, Gal1,6Gal, and
Gal1,3-galactofuranose (Galf) (5). Chagasic anti--Gal
IgG can agglutinate and cause parasite lysis by a comple-
ment-mediated (6) or -independent (4, 5, 29) mechanism,
corroborating the aforementioned hypothesis.
In P. brasiliensis, we found that both PCM and Chagasic
anti--Gal IgG reacted intensely with extracellular vesicles, in
contrast with the modest reaction evoked by natural anti--Gal
antibodies. These observations are similar to those reported by
Almeida et al. (4) for trypomastigote surface mucins, which
showed enhanced affinity for antibodies from patients with
chronic Chagas’ disease compared to natural anti--Gal. Our
results therefore suggest the presence in P. brasiliensis of a
variety of nonreducing terminal -linked galactopyranosyl
epitopes that are probably similar to those found in T. cruzi
mucins, as judged by the strong reactions with Chagasic anti-
-Gal. The presence of -Gal residues in P. brasiliensis vesicles
was unequivocally shown after treatment of both whole and
fractionated vesicles with -galactosidase. On the other hand,
inhibition by -galactosidase of vesicle reactivity with MOA
lectin was around 75%, compared with approximately 50% for
Chagasic anti--Gal and about 35% for PCM anti--Gal, while
almost complete inhibition was achieved when lipid-free vesi-
cle fractions were tested with anti--Gal. These differences
may be attributed to different degrees of accessibility of the
enzyme to the cleavable residues under our ELISA conditions.
It is also noteworthy that Ch anti--Gal antibodies can recog-
nize a broader variety of linkages than does the MOA lectin.
The latter is highly specific for terminal Gal1,3Gal disaccha-
rides of blood type B, with enhanced affinity achieved after
addition of 1,4GlcNAc or 1,2-L-Fuc; however, it does not
bind to Gal1,2Gal and Gal1,6Gal disaccharides (41).
In T. cruzi, -Gal epitopes are part of long, mostly
branched O-linked glycans of mucins (5). In P. brasiliensis, a
broad smear characterized immunoblotting reactions of
anti--Gal with both vesicle preparations and cell extracts,
suggesting antibody binding to highly glycosylated compo-
nents (not shown). We found evidence for the localization of
-Gal epitopes in glycoproteins, where they are at least
partially distributed in O-linked glycan chains and possibly
also in N-linked chains in Pb3. Localization in glycolipids
seems to occur, but those results should be better investi-
gated. Eukaryotic O-glycans are usually attached to the
-hydroxyl group of serines or threonines. Unlike those of
mammals and parasites, fungal O-glycans, such as those
from C. albicans, S. cerevisiae, and Pichia pastoris, tend to be
short (2 to 5 residues) and generally linear, and the main
component is mannose (reviewed in reference 19). Never-
theless, terminal or side -1,2- and -1,3-galactopyranose
(Galp) residues linked to mannose have been found in As-
pergillus and Schizosaccharomyces pombe, where an -1,2-
galactosyltransferase uses UDP-galactose as a sugar donor
(19). Examples of fungal galactose residues linked to other
galactoses can be found in polysaccharides (1, 18).
In P. brasiliensis, we have found two annotated galactosyltrans-
ferase sequences in the Pb3 and Pb18 genomes released by
the Broad Institute (http://www.broadinstitute.org/annotation
/genome/paracoccidioides_brasiliensis). In this fungus, a high-mo-
lecular-mass extracellular galactomannan bears terminal -Galp
residues linked to mannose (30). Galactomannans extracted from
the mycelium cell wall have -Galf1,6-Manp1,2 side chains,
which in the yeast phase contain mostly -Galf instead of the rare
-Galf (2). Terminal -galactofuranosyl residues are commonly
found in galactomannans of pathogenic fungi and are responsible
for cross-reactivity in serum diagnosis, as exemplified in P. brasil-
iensis by the main diagnostic glycoprotein gp43 (7, 31). It is also
noteworthy that -Galf is an essential part of the carbohydrate
epitope Galf1,6(Manp1,3)Manp1,2-inositol contained in P.
brasiliensis glycosphingolipids (35).
In C. neoformans, vesicles containing GXM are produced
during macrophage infection, suggesting a role in the patho-
genesis of the microorganism (33). In addition, recent in vitro
data showed that vesicles can be incorporated by macrophages
and stimulate expression of tumor necrosis factor alpha (TNF-
), transforming growth factor beta (TGF-), interleukin 10
(IL-10), and nitric oxide, and hence, they increase the phago-
cyte microbicidal capacity (26). When -Gal-rich vesicles se-
creted by T. cruzi infective trypomastigote forms were admin-
istered in vivo to BALB/c mice, increased tissue parasitism and
a severe inflammatory reaction by stimulation of IL-4 and
FIG. 9. (A) Effect of -elimination or Endo H treatment on reac-
tivity with anti--Gal (5 g/ml). Pb3 and Pb18 vesicle or cell lysate
preparations were compared for reactivity with PCM and Ch anti--
Gal before and after treatment. The percent inhibition is shown for
representative results from replicate or triplicate experiments. (B) Lip-
id-free fractions (200 ng of protein/well) from Pb3 and Pb18 vesicles
reacted with both PCM and Ch anti--Gal (2.5 g/ml); the percent
inhibition after treatment with -galactosidase () is indicated. Simi-
lar results were obtained in replicates for Pb3, carried out with both
200 ng and 500 ng of protein/well. The error bars indicate standard
deviations.
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IL-10 synthesis were observed (37). In P. brasiliensis, we ana-
lyzed extracellular vesicles from both Pb18 and Pb3, which
evoke experimental PCM in B10.A mice that have distinct
outcomes (13). We observed that the immunoblotting anti-
genic profiles of Pb3 and Pb18 vesicle preparations had a few
differentially reactive components (Fig. 3). Preliminary data
from our group suggested that vesicle preparations from these
two isolates are able to stimulate cytokine expression of mac-
rophages in vitro and that these responses can vary according
to the isolate (M. C. Vallejo, L. Ganiko, I. C. Almeida, and R.
Puccia, unpublished data); however, the participation of P.
brasiliensis -Gal epitopes in the host’s cellular immune re-
sponse is so far speculative.
Fungal components carrying -Gal epitopes recognized by
both anti--Gal and MOA lectin could be observed, not only in
P. brasiliensis vesicles, but also along the cell wall and in intra-
cellular vacuoles, where labeling seemed to target vesicle-like
structures distributed inside and near the vacuolar membrane.
Vacuoles are important fungal components where diverse
membrane-trafficking pathways can converge. They contain
molecules coming from the secretory pathway on their way to
be secreted, as well as molecules that have been endocytosed
or derived from autophagy that are meant to be disposed of or
degraded (40). The biogenesis of fungal extracellular vesicles
has recently been addressed using S. cerevisiae mutants with
defects in conventional secretion pathways and multivesicular
body trafficking (27, 28). Vesicular export has not been affected
in any of the mutants analyzed; however, the relative peptide
abundances varied in a considerable number of vesicular pro-
teins. In mutants with affected Golgi-dependent secretion
mechanisms, a decrease in the rate of vesicle release was ob-
served. These results suggest that vesicular transport involves
conventional and unconventional pathways. Components bear-
ing -Gal epitopes should use the conventional secretory path-
way in order to be glycosylated, but they seem to be stored in
P. brasiliensis vacuoles that resemble multivesicular bodies.
This supposition is consistent with the existence of different
points of convergence between Golgi-derived and endosome-
related secretory pathways (39).
The finding of extracellular vesicles in P. brasiliensis opens
new areas to explore in terms of the host-parasite relation-
ship. Antigenic components are exported by this route, and
also molecules that can interact with the host’s cellular
immune system. The role played by P. brasiliensis vesicles in
vivo and the differences in contents that could account for
distinct disease outcomes depending on the isolate are sub-
jects to be addressed. The present work describes the pres-
ence of highly immunogenic and complex -galactosyl
epitopes in components that are transported by vesicles to
the extracellular milieu, stored in intracellular vacuoles, and
abundantly seen on the cell wall, where they are likely to be
transiently trapped on their way outward. The importance of
these carbohydrate epitopes in the interface with the host
remains to be explained.
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